Kirkwood JM - Search Results

1

Importance of glycolysis and oxidative phosphorylation in advanced melanoma.

Ho J, de Moura MB, Lin Y, Vincent G, Thorne S, Duncan LM, Hui-Min L, Kirkwood JM, Becker D, Van Houten B, Moschos SJ. Ho J, et al. Among authors: kirkwood jm. Mol Cancer. 2012 Oct 9;11:76. doi: 10.1186/1476-4598-11-76. Mol Cancer. 2012. PMID: 23043612 Free PMC article.

2

Analysis of two human monoclonal antibodies against melanoma.

Yeilding NM, Gerstner C, Kirkwood JM. Yeilding NM, et al. Among authors: kirkwood jm. Int J Cancer. 1992 Dec 2;52(6):967-73. doi: 10.1002/ijc.2910520623. Int J Cancer. 1992. PMID: 1459738

3

Molecular analysis of melanoma precursor lesions.

Wang Y, Rao U, Mascari R, Richards TJ, Panson AJ, Edington HD, Shipe-Spotloe JM, Donnelly SS, Kirkwood JM, Becker D. Wang Y, et al. Among authors: kirkwood jm. Cell Growth Differ. 1996 Dec;7(12):1733-40. Cell Growth Differ. 1996. PMID: 8959342

4

Systemic interferon-alpha (IFN-alpha) treatment leads to Stat3 inactivation in melanoma precursor lesions.

Kirkwood JM, Farkas DL, Chakraborty A, Dyer KF, Tweardy DJ, Abernethy JL, Edington HD, Donnelly SS, Becker D. Kirkwood JM, et al. Mol Med. 1999 Jan;5(1):11-20. Mol Med. 1999. PMID: 10072444 Free PMC article.

5

A phase III randomized trial of dacarbazine and carboplatin with and without tamoxifen in the treatment of patients with metastatic melanoma.

Agarwala SS, Ferri W, Gooding W, Kirkwood JM. Agarwala SS, et al. Among authors: kirkwood jm. Cancer. 1999 May 1;85(9):1979-84. Cancer. 1999. PMID: 10223239 Clinical Trial.

6

Macroscopic spectral imaging and gene expression analysis of the early stages of melanoma.

Yang P, Farkas DL, Kirkwood JM, Abernethy JL, Edington HD, Becker D. Yang P, et al. Among authors: kirkwood jm. Mol Med. 1999 Dec;5(12):785-94. Mol Med. 1999. PMID: 10666478 Free PMC article.

7

Analysis of therapeutic and immunologic effects of R(24) anti-GD3 monoclonal antibody in 37 patients with metastatic melanoma.

Kirkwood JM, Mascari RA, Edington HD, Rabkin MS, Day RS, Whiteside TL, Vlock DR, Shipe-Spotloe JM. Kirkwood JM, et al. Cancer. 2000 Jun 15;88(12):2693-702. Cancer. 2000. PMID: 10870051 Clinical Trial.

8

Temozolomide in combination with interferon alpha-2b in patients with metastatic melanoma: a phase I dose-escalation study.

Agarwala SS, Kirkwood JM. Agarwala SS, et al. Among authors: kirkwood jm. Cancer. 2003 Jan 1;97(1):121-7. doi: 10.1002/cncr.11041. Cancer. 2003. PMID: 12491513 Free article. Clinical Trial.

9

Fluorescence imaging analysis of upstream regulators and downstream targets of STAT3 in melanoma precursor lesions obtained from patients before and after systemic low-dose interferon-alpha treatment.

Smith AP, Kirkwood JM, Edington HD, Jukic DM, Farkas DL, Becker D. Smith AP, et al. Among authors: kirkwood jm. Mol Imaging. 2003 Jan;2(1):65-73. doi: 10.1162/15353500200302157. Mol Imaging. 2003. PMID: 12926238

10

Present status and future prospects for adjuvant therapy of melanoma: time to build upon the foundation of high-dose interferon alfa-2b.

Moschos SJ, Kirkwood JM, Konstantinopoulos PA. Moschos SJ, et al. Among authors: kirkwood jm. J Clin Oncol. 2004 Jan 1;22(1):11-4. doi: 10.1200/JCO.2004.10.952. Epub 2003 Dec 9. J Clin Oncol. 2004. PMID: 14665613 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

610 results

Search Page

Filters